Navigation Links
Cedars-Sinai study: How does a 'good' protein hurt brain cells after clot-induced stroke?

LOS ANGELES -- The National Institutes of Health has awarded a four-year, $1.4 million grant to Cedars-Sinai's Department of Neurology to study an unexpected recent discovery: After ischemic stroke the type caused by a clogged artery but with no bleeding into the brain a normal protein that plays a positive role in blood clotting escapes intact arteries and damages healthy brain cells.

"We knew thrombin leaked out during hemorrhagic strokes those in which an artery ruptures and we knew that in large amounts it killed brain cells. But we decided to see if there was thrombin after ischemic stroke, and, surprisingly, there was a lot, and it was causing major damage to brain cells. When we injected a drug that counters the effects of thrombin, stroke symptoms got better," said Patrick D. Lyden, MD, chair of the Department of Neurology and the Carmen and Louis Warschaw Chair in Neurology at Cedars-Sinai.

He was senior author of a 2010 article in the journal Stroke that described this phenomenon and suggested possible underlying mechanisms. The new grant, he said, will let researchers delve more deeply: Where is the thrombin coming from? What kinds of cells does it kill? What factors inhibit or enhance its effects?

Lyden will continue his work with Roger Y. Tsien, a scientist at the University of California, San Diego. He is one of three winners of the 2008 Nobel Prize in chemistry for development of green fluorescent protein.

Lyden's study will use fluorescence in rats and mice to light up thrombin and follow its migration and interactions with other molecules in blood vessels and brain tissue.

This is the first NIH funding directly awarded to the Department of Neurology, evidence of its growth since Lyden's arrival in 2009. He and other researchers are also supported by other NIH grants received before he joined Cedars-Sinai.

Contact: Sandy Van
Cedars-Sinai Medical Center

Page: 1

Related medicine news :

1. TGen and Virginia G. Piper Cancer Center form drug development collaboration with Cedars-Sinai
2. Cedars-Sinai scientists, physicians to be key presenters at World Stem Cell Summit
3. Cedars-Sinai movement disorders expert on international task force for dystonia treatment
4. Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors
5. Cedars-Sinais mobile medical clinics receive $500,000 grant from California Community Foundation
6. Cedars-Sinai to hold first annual conference on stem cell therapies for neurological disorders
7. Cedars-Sinais mobile medical clinics receive grant from George Hoag Family Foundation
8. Cedars-Sinai research team awarded $1.9 million from CIRM to develop new tools and technologies
9. Cedars-Sinai Medical Genetics Institute director honored with lifetime achievement award
10. Cedars-Sinai nano-drug hits brain-tumor target found in 2001
11. Cedars-Sinai awarded $1.9 million from CIRM to develop stem cell treatments for osteoporosis
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... ... by UPMC and KingMed Diagnostics researchers. Their review of ... that consultation with UPMC pathologists resulted in significantly altered treatment plans for more ...
(Date:11/30/2015)... ... 30, 2015 , ... ”Dying Words: The AIDS Reporting of Jeff Schmalz and ... to coincide with World AIDS Day. The multi-media project will be in audio documentary ... as he was dying of the disease. , A collaborative effort led by author, ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... promoting breast and prostate cancer education and prevention—is joining forces with the award-winning ... philanthropy and Hollywood elegance on December 7, 2015 at the Union League of ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... their exclusive channel partner for the Nutraceutical Specialties products into oral solid dosage ... effective immediately. , “We are pleased to announce our expanded distribution agreement ...
(Date:11/30/2015)... ... November 30, 2015 , ... California-based i2i ... years, announced today that Michigan-based Family Health Center (FHC) has selected i2iTracks as ... years, FHC was awarded the largest Affordable Care Act grant for Federally Qualified ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... YORK , Nov. 30, 2015 Cumberland Pharmaceuticals ... will present live at on December 3, 2015. ... --> TIME: 3:15p.m. ET LINK: ... ET LINK: --> ... online event where investors are invited to ask the company ...
(Date:11/30/2015)... Nov. 30, 2015 Varian Medical Systems (NYSE: VAR ... educational partnership with Apollo Hospitals Group, the largest hospital chain in ... help train radiation technologists in the country. The MoU was signed ... Knowledge, and Ashok Kakkar , Varian,s India ... India , Varian intends to deploy its Access ...
(Date:11/30/2015)... and BOSTON , November 30, 2015 ... develop potential new medicines directed at up to 10 ... --> PFE ) to research and develop ... protein-coupled receptor (GPCR) targets across multiple therapeutic areas. ... drug discovery and development company and wholly-owned subsidiary of ...
Breaking Medicine Technology: